A new study compares the benefits and risks of taking GLP-1 medications for weight loss, including risks of dementia, ...

Ozempic and Wegovy are being linked to surprising effects on overall health. A new study finds these drugs may improve heart ...

GLP-1 medications like Ozempic, Wegovy, and Mounjaro are linked to reduced risks of dementia, heart failure, and severe ...

Research shows that GLP-1 receptor agonists like Ozempic can help you drop weight, manage diabetes ... your risk of ...

News research shows GLP-1 medications may help treat a wide range of conditions, from addiction and dementia to heart disease ...

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the ...

Unlike subcutaneous fat that lies just beneath our skin, visceral fat accumulates around our internal abdominal organs, ...

Over 2 million people were included in new research to test these drugs against 175 different health outcomes.

Losing excess weight would in turn improve health. For example, lower levels of sleep apnoea – when breathing stops and ...

Research shows that people who take these weight-loss medications may have a lower risk of dementia and numerous other health ...

Vaccines, antibiotics, antiviral medications and anti-inflammatory drugs are all associated with a reduced risk of dementia, ...

As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a study has ...